Clinical Trial Update: Overnight Switch From Rasagiline To Safinamide [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial reports an overnight switch from rasagiline to safinamide in Parkinson disease, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• RASAGILINE (rasagiline)
• Safinamide (Safinamide)

Snippet

Sponsor: IRCCS San Raffaele Roma | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED